Inventor
COHEN BENJAMIN M
US25 patents
⚠️ This page may combine multiple inventors who share the name “COHEN BENJAMIN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
15 patentsUS9221788B2Dec 29, 2015
Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP21 citations92
US9751853B2Sep 5, 2017
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
CELGENE CORP4 citations84
US9629849B2Apr 25, 2017
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP7 citations84
US9309220B2Apr 12, 2016
Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
CELGENE CORP14 citations83
US9067912B2Jun 30, 2015
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,8-dione
CELGENE CORP5 citations83
US10463672B2Nov 5, 2019
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US9884062B2Feb 6, 2018
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US9975872B2May 22, 2018
Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
CELGENE CORP2 citations72
US9969713B2May 15, 2018
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
CELGENE CORP1 citations63
US9249121B2Feb 2, 2016
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
CELGENE CORP2 citations63
US12343346B2Jul 1, 2025
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US11241439B2Feb 8, 2022
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US9303014B2Apr 5, 2016
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
CELGENE CORP1 citations61
US9266858B2Feb 23, 2016
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
CELGENE CORP1 citations61
US10596180B2Mar 24, 2020
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations52
BRISTOL MYERS SQUIBB CO
3 patentsUS12269840B2Apr 8, 2025
Process for the preparation of a cyclic dinucleotide
BRISTOL MYERS SQUIBB CO1 citations57
US11919863B2Mar 5, 2024
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
BRISTOL MYERS SQUIBB CO0 citations56
US11236048B2Feb 1, 2022
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
BRISTOL MYERS SQUIBB CO0 citations56